Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price

Type II Diabetes, An Issue of Endocrinology and Metabolism Clinics

9781416026860
342.67 zł
308.40 zł Save 34.27 zł Tax included
Lowest price within 30 days before promotion: 308.40 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Type II diabetes is a chronic condition that results when the bodys insulin does not work effectively; it affects up to 6% of the US population, and has been growing in prevalence over the past decade. This issue covers all areas of non insulin-dependent diabetes including insulin therapy and insulin strategies, hypertension management, glycemic management, multifactorial management, dyslipidemia, and novel pharmacologic agents.
Product Details
Saunders
37207
9781416026860
9781416026860

Data sheet

Publication date
2005
Issue number
1
Cover
hard cover
Pages count
240
Weight (g)
499
  • 1. Early Insulin Therapy in Type 2 Diabetes: Exploring Insulin Cardioprotection and Beta Cell Preservation (Gerstein and Rosenstock)
    2. Type 2 Diabetes: A Pandemic Disease (Harris)
    3. The Insulin Resistance Syndrome: One Disease, Multiple Consequences (Reaven)
    4. Dual Defects in the Disease Continuum of Type 2 Diabetes: Insulin Resistance and Beta Cell Deficiency (Kahn)
    5. Type 2 Diabetes as a Cardiovascular Equivalent (Haffner)
    6. Dyslipidemia Management in Type 2 Diabetes and the ATP III (Goldberg)
    7. Hypertension Management in Type 2 Diabetes and the JNC VII (Sowers)
    8. Glycolic Management in Type 2 Diabetes: Emerging Strategies with Oral Combination Agents (Riddle)
    9. Multifactor Management in Type 2 Diabetes (Kendall)
    10. Potential Cardioprotective Effects of Insulin Sensitizers (Fonseca)
    11. Insulin Strategies in the Hospital Setting and the CCU (Moghissi and Hirsch)
    12. Novel Pharmacologic Agents for Type 2 Diabetes (Ratner)
    13. Preventing Type 2 Diabetes: How Far Have We Gone and What Else Do We Need? (Sherwin)
    14. Prevention of Cardiovascular Outcomes in Type 2 Diabetes: Trials in the Horizon (Buse)
    15. Emerging Evidence-Based Outcomes from Cholesterol and Hypertension Prevention Trials: Cardiovascular Events in Type 2 Diabetes (Nissen)
Comments (0)
Viewed products

  • Frequently purchased together

    No products available